SouthState Corp’s Halozyme HALO Stock Holding History

SouthState Corp’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$627	Buy	+8	New	+$545	﹤0.01%	1191
2025 Q2	–	Sell	-9	Closed	-$575	–	1688
2025 Q1	$575	Buy	+9	New	+$523	﹤0.01%	1464

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SouthState Corp's HALO Position: Q2 2026 in Review

SouthState Corp opened a new position in Halozyme (HALO) in Q2 2026: 8 shares worth $627. The stake represents ﹤0.01% of the portfolio and ranks #1191 among its holdings. This is a return to the name: SouthState Corp previously reported a position in HALO as recently as Q1 2025.

SouthState Corp first reported a position in HALO in Q1 2025 and has held it in 2 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

SouthState Corp held 8 shares of Halozyme worth $627 as of Q2 2026.
Halozyme was a new SouthState Corp position in Q2 2026.
Halozyme made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1191 holding.
SouthState Corp first reported a position in Halozyme in Q1 2025 and has held it in 2 quarters since.
674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.